Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 3 studies | 24% ± 4% | |
| epithelial cell | 3 studies | 23% ± 10% | |
| astrocyte | 3 studies | 19% ± 1% | |
| glutamatergic neuron | 3 studies | 38% ± 20% | |
| oligodendrocyte precursor cell | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 1347.68 | 180 / 180 | 100% | 22.39 | 428 / 430 |
| breast | 100% | 1194.72 | 459 / 459 | 99% | 11.61 | 1112 / 1118 |
| bladder | 100% | 1031.14 | 21 / 21 | 99% | 11.37 | 501 / 504 |
| intestine | 100% | 1064.09 | 966 / 966 | 99% | 11.70 | 523 / 527 |
| uterus | 100% | 1436.06 | 170 / 170 | 99% | 11.67 | 455 / 459 |
| stomach | 100% | 894.86 | 358 / 359 | 99% | 12.60 | 283 / 286 |
| prostate | 100% | 1168.91 | 244 / 245 | 99% | 11.63 | 497 / 502 |
| esophagus | 100% | 976.85 | 1444 / 1445 | 98% | 14.25 | 180 / 183 |
| lung | 99% | 972.83 | 575 / 578 | 99% | 10.17 | 1141 / 1155 |
| thymus | 100% | 1460.26 | 653 / 653 | 98% | 9.19 | 593 / 605 |
| pancreas | 99% | 700.97 | 325 / 328 | 99% | 9.44 | 176 / 178 |
| kidney | 100% | 1123.72 | 89 / 89 | 98% | 12.11 | 882 / 901 |
| skin | 100% | 1301.17 | 1808 / 1809 | 97% | 8.45 | 460 / 472 |
| brain | 96% | 622.21 | 2548 / 2642 | 98% | 10.18 | 692 / 705 |
| adrenal gland | 100% | 1082.90 | 258 / 258 | 92% | 6.05 | 212 / 230 |
| liver | 99% | 652.37 | 224 / 226 | 93% | 6.32 | 376 / 406 |
| spleen | 100% | 1318.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.97 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.75 | 1 / 1 |
| adipose | 100% | 953.97 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1042.00 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 473.77 | 829 / 861 | 0% | 0 | 0 / 0 |
| muscle | 95% | 400.35 | 763 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 5.13 | 71 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 7.98 | 25 / 29 |
| peripheral blood | 76% | 522.69 | 710 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0019509 | Biological process | L-methionine salvage from methylthioadenosine |
| GO_0019284 | Biological process | L-methionine salvage from S-adenosylmethionine |
| GO_0042995 | Cellular component | cell projection |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0001650 | Cellular component | fibrillar center |
| GO_0046523 | Molecular function | S-methyl-5-thioribose-1-phosphate isomerase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MRI1 |
| Protein name | Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein) |
| Synonyms | UNQ6390/PRO21135 MRDI |
| Description | FUNCTION: Catalyzes the interconversion of methylthioribose-1-phosphate (MTR-1-P) into methylthioribulose-1-phosphate (MTRu-1-P). Independently from catalytic activity, promotes cell invasion in response to constitutive RhoA activation by promoting FAK tyrosine phosphorylation and stress fiber turnover. . |
| Accessions | Q9BV20 ENST00000319545.12 [Q9BV20-2] ENST00000040663.8 [Q9BV20-1] |